APM
PLRX icon

Avidity Partners Management’s Pliant Therapeutics PLRX Stock Holding History

Avidity Partners Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-916,600
Closed -$16.6M – 98
2023
Q2 		$16.6M Sell
916,600
-1,748,400
-66% -$41.4M 0.58% 58
2023
Q1 		$70.9M Buy
2,665,000
+424,600
+19% +$12.1M 2.35% 16
2022
Q4 		$43.3M Buy
2,240,400
+259,300
+13% +$5.42M 1.01% 34
2022
Q3 		$41.4M Buy
+1,981,100
New +$37.9M 0.9% 41

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return